Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson’s disease

Multivariate and Propensity Score Matching Software with Automated Balance Optimization: TheMatchingPackage forR

(2015) Jasjeet S. Sekhon   Journal of Statistical Software

Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson’s disease in Sweden

(2012) Ivar Sønbø Kristiansen et al.   Applied Health Economics and Health Policy

Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s disease

(2011) H.H. Fernandez et al.   CURRENT MEDICAL RESEARCH AND OPINION

Motor complications in Parkinson's disease: Ten year follow-up study

(2010) Iria Cabo López et al.   MOVEMENT DISORDERS

Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy

(2010) Peter P. Urban et al.   MOVEMENT DISORDERS

Hallucinations and sleep disorders in PD: Ten-year prospective longitudinal study

(2010) C. G. Goetz et al.   NEUROLOGY

Progression of Parkinson's disease in the clinical phase: potential markers

(2009) Walter Maetzler et al.   LANCET NEUROLOGY

Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life

(2009) Holger Honig et al.   MOVEMENT DISORDERS

Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease

(2009) David Devos et al.   MOVEMENT DISORDERS

Comparison of apomorphine and levodopa infusions in four patients with Parkinson’s disease with symptom fluctuations

(2008) D. Nyholm et al.   ACTA NEUROLOGICA SCANDINAVICA

Enteral Levodopa/Carbidopa Infusion in Advanced Parkinson Disease

(2008) Dag Nyholm et al.   CLINICAL NEUROPHARMACOLOGY

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS